ClinicalTrials.Veeva

Menu

The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies

Seattle Children's Healthcare System logo

Seattle Children's Healthcare System

Status

Enrolling

Conditions

Hirschsprung Disease
Gastrointestinal Complication
Midgut Volvulus
Gastroschisis
Omphalocele
Intestinal Obstruction

Treatments

Dietary Supplement: Exclusive Human Milk
Dietary Supplement: Standard of Care

Study type

Interventional

Funder types

Other

Identifiers

NCT06072976
STUDY00004330: CGP Milk

Details and patient eligibility

About

This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.

Enrollment

116 estimated patients

Sex

All

Ages

Under 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants with gastroschisis, giant omphalocele, intestinal atresia, mid-gut volvulus, hirschsprungs disease.

Exclusion criteria

  1. Infant has already been on feeds
  2. Infants <34 weeks gestation
  3. Parents with contraindications to providing milk (i.e. drug use-cocaine, fentanyl, meth BUT oxy/suboxone/marijuana OK)
  4. Complicated gastroschisis
  5. Short gut syndrome
  6. Additional congenital anomalies that affect ability to tolerate milk (i.e. cyanotic congenital heart disease BUT kidney disease ok)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

116 participants in 2 patient groups

Exclusive human milk
Experimental group
Description:
Mothers will consent to providing DHM if MOM is not available. If the infant reaches 100 ml/kg/day of feeds (one feed advancement prior to full feeds) and MOM remains unavailable, they will transition to formula in preparation for discharge. Infants cannot be discharged on donor milk.
Treatment:
Dietary Supplement: Exclusive Human Milk
Standard of care
Experimental group
Description:
Mothers will consent to providing DHM (if qualifies per hospital policy) or formula if MOM is not available. Infants are only eligible to receive donor milk only if 1) MOM is not available 2) if infant initiates feeds before day 3 of age. The donor milk feed would be stopped on day 5 of age. After day five of age, the infant will receive formula if MOM is not available. This is congruent with the current donor milk policy (see Policy #12785). It is highly unlikely given these infants would receive any donor milk because these infants require surgery and often are waiting return of bowel function . The median age of initiation of feeds is 12 days of age for infants with gastroschisis (PMID: 33647253) which exceeds the days of what the hospital policy says for eligibility which is initiates feed before day 3 of age. If the infant does not qualify for any donor milk and MOM is not available, the infant will receive formula
Treatment:
Dietary Supplement: Standard of Care

Trial contacts and locations

1

Loading...

Central trial contact

Leonel Arellano

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems